Skip to main content
. 2018 Apr 25;21(3):163–169. doi: 10.1016/j.cjtee.2017.10.006

Table 1.

Characteristics of the study population [data are expressed as n (%)].

Variables In-hospital mortality
p value OR (95% CI)
Yes No
No. of patients 331 38 293
Age (years)a* 83.7 (67–98) 87.7 (81–97) 83.2 (67–98) <0.001
Age (years)c
 ≤ 84 171 (51.7) 13 (34.2) 158 (53.9) 0.05
 85-89 87 (26.3) 12 (31.6) 75 (25.6)
 ≥ 90 73 (22.1) 13 (34.2) 60 (20.5)
Sexc
 Male 242 (73.1) 15 (39.5) 74 (25.3) 0.07
 Female 89 (26.9) 23 (60.5) 219 (74.7)
Residencec
 Home 286 (86.4) 33 (86.8) 253 (86.4) 0.61
 Nursing 45 (13.6) 5 (13.2) 40 (13.7)
Fracture patternc
 Femoral neck 191 (57.7) 17 (44.7) 174 (59.4) 0.21
 Pertrochanteric 124 (37.5) 19 (50.0) 105 (35.8)
 Subtrochanteric 16 (4.8) 2 (5.3) 14 (4.8)
Fracture patternc
 Intracapsular 191 (57.7) 17 (44.7) 174 (59.4) 0.11
 Extracapsular 140 (42.3) 21 (55.3) 119 (40.6)
Parker and Palmer scorea* 5.1 (1–9) 3.4 (1–9) 6.3 (4–9) <0.001
Dependent mobilityc 66 (19.9) 23 (60.5) 43 (14.7) <0.001 8.9 (4.3–18.4)
Katz scorea* 4.7 (0–6) 3.5 (0–6) 5.4 (3–6) <0.001
Dependence patientsc 98 (29.6) 28 (73.7) 70 (23.9) <0.001 8.9 (4.1–19.2)
Hemoglobin (g/L)a* 125 (91–142) 117 (91–128) 123 (109–142) 0.004
Hemoglobin (g/L)c
 <100 30 (9.1) 9 (23.7) 21 (7.2) 0.003 4.0 (1.6–9.5)
 ≥100 301 (90.9) 29 (76.3) 272 (92.8)
Anticoagulant medicationc 23 (7.0) 3 (7.9) 20 (6.8) 0.73
Antiaggregant medicationc 83 (25.1) 2 (5.3) 81 (27.7) <0.001 0.14 (0.03–0.61)
Time to surgery (days)b* 3.6 ± 2.1 4.1 ± 2.8 3.5 ± 2.0 0.36
Time to surgery > 2 daysc 204/310 (65.8) 15/24 (62.5) 189/286 (66.1) 0.44
Treatmentc
 Surgical 310 (93.6) 24 (63.1) 286 (97.6) <0.001 23.8 (8.7–64.6)
 Non-surgical 21 (6.4) 14 (36.9) 7 (2.4)
Surgical treatmentc
 Cemented hemiarthroplasty 177 (57.0) 15 (62.5) 162 (56.6) 0.47
 Screws 16 (5.1) 0 16 (5.5)
 Proximal femoral nail 117 (37.9) 9 (37.5) 108 (37.9)

* Means and ranges.

a

Student's t-test.

b

Mann-Whitney U test.

c

Chi-square test.